Impact of sex on the outcomes of deceased donor liver transplantation

Table 1 Descriptive variables stratified by recipient sex, n (%)

	Male	Female	P value
	518 (66.5)	261 (33.5)
Donor sex			0.001
Male	326 (62.9)	59 (22.6)
Female	192 (37.1)	202 (77.4)
Etiology			0.001
Acute liver failure	18 (3.5)	34 (13.0)
Alcohol	149 (28.8)	46 (17.6)
HBV/HCV	160 (30.9)	53 (20.3)
HCC	152 (29.3)	45 (17.2)	0.001
NASH	58 (11.2)	20 (7.7)
PSC	53 (10.2)	12 (4.6)
Others1	80 (15.4)	96 (36.8)
Milan criteria
HCC within Milan	132 (86.8)	39 (86.7)	0.9756
HCC beyond Milan	20 (13.2)	6 (13.3)
Comorbidities	364 (70.3)	162 (62.1)	0.021
Coronary artery disease	83 (16.0)	25 (9.6)	0.014
Diabetes	140 (27.0)	41 (15.7)	0.001
Peripheral vascular disease	5 (1.0)	2 (0.8)	0.781
COPD	75 (14.5)	33 (12.6)	0.484
Smoker	131 (25.3)	49 (18.8)	0.042
High urgency transplant	25 (4.8)	41 (15.7)	0.001
Intraoperative blood transfusion	217 (41.9)	115 (44.1)	0.563
Perioperative death	89 (17.2)	39 (14.9)	0.426

¹Hepatopulmonary syndrome, hyperoxaluria, polycystic liver disease, hepatoblastoma, Budd Chiari, neuroendocrine tumor, Wilson’s disease, primary biliary cirrhosis, autoimmune hepatitis, cryptogenic. COPD: Chronic obstructive pulmonary disease; HBV: Hepatitis B virus; HCC: Hepatocellular carcinoma; HCV: Hepatitis C virus; NASH: Non-alcoholic steatohepatitis; PSC: Primary sclerosing cholangitis.